Skip to main content
. Author manuscript; available in PMC: 2008 Feb 20.
Published in final edited form as: Neurogenetics. 2003 Dec 2;5(1):27–34. doi: 10.1007/s10048-003-0165-9

Table 2.

Summary of the clinical features of the seven patients (CK creatine kinase, ND no data)

Patient 1 2 3 4 5 6 7
Sex F M F F F F M
Age of onset Birth Birth Birth 4 months 2 months Birth Birth
Current age (years) 7 6 6 5 6 12 3
Serum CK 4,400 IU/I 5,500 IU/I Sat 7,330 IU/I 2,978 IU/I 2,600 IU/I 4,997 IU/I 1,370 IU/I
Maximal motor milestone Sat unsupported unsupported Sat unsupported Sat unsupported Sat unsupported Sat unsupported Sat unsupported
Contractures Yes Yes Yes Yes Yes Yes Yes
Hypertrophy Calf Calf No Calf No Tongue Calf
Mental Retardation Yes Yes Yes Yes Yes Yes Yes
Head circumference − 2 SD − 2 SD − 2 SD − 2 SD − 2 SD − 2 SD − 2 SD
White Matter Changes Yes (3 years) Yes (3 years) No (6 years) No (5 years) Yes (3 years) Yes (1 year)/+/−(4 years)/No (12 years) Yes (2.5 years)
Cerebellar Cysts Yes Yes Yes Yes ND Yes Yes
Hypoplasia of vermis Yes Yes Yes No ND Yes Yes
Microcephaly Yes Yes Yes Yes Yes Yes Yes
Eye involvement No Strabismus No No No Ophthalmoplegia ND
left ventricular Left ventricular
Cardiac function Normal Normal ND hypertrophy ND dilatation Normal
Respiratory function Normal Normal Normal Normal Normal Mechanical ventilation Normal
Scoliosis Yes Yes No Yes No Vertebral arthrodesis No